Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Bacteria, specifically in the form of probiotics, have been studied for their potential to support or treat autoimmune disorders. The primary scientific rationale stems from the role of the gut microbiome in immune system regulation. Several autoimmune conditions, such as inflammatory bowel disease (IBD), type 1 diabetes, and multiple sclerosis, have been associated with dysbiosis—an imbalance in the composition of gut bacteria. Clinical studies and animal models suggest that manipulating the gut microbiota with certain probiotic strains may help reduce inflammation, modulate immune responses, and potentially ameliorate symptoms of some autoimmune diseases.

However, while there is a growing body of evidence supporting these effects, the efficacy varies widely depending on the type of autoimmune disorder, the specific bacterial strains used, and individual patient differences. Most of the evidence is preliminary, coming from small-scale human trials and animal research, with some positive findings in conditions like ulcerative colitis and Crohn's disease. Larger, well-designed clinical trials are still needed to establish definitive benefits and to determine optimal strains and dosages.

In summary, the use of bacteria (probiotics) in autoimmune disorders is supported by emerging scientific evidence, but it is not yet considered a standard or universally effective therapy. The approach remains promising but experimental, with a moderate level of supporting evidence (rated 3/5).

More about bacteria
More about Autoimmune Disorders

Other ingredients used for Autoimmune Disorders

Other health conditions supported by bacteria

Products containing bacteria